Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dursun

Showing results (21-30 of 190) with videos related to

Pageof 19
Sort By:
The American Journal of Medicine|May 1, 1995
Hypocholesterolemia and human immunodeficiency virus-1 (HIV-1) infectionS M Dursun, M A Reveley
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1994
Obsessive-compulsive symptoms and clozapineS M Dursun, M A Reveley
Journal of Psychopharmacology (Oxford, England)|October 19, 2006
Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapyHenry A Nasrallah, Serdar M Dursun
British Journal of Pharmacology|August 1, 1993
The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouseS M Dursun, S L Handley
Psychological Medicine|March 1, 1997
Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open studyS M Dursun, M A Reveley
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1992
Serotonin, eating disorders, and HIV infectionS M Dursun, S L Handley
BMJ (Clinical Research Ed.)|July 17, 1993
Clozapine in the management of schizophrenia. Clozapine has unique pharmacological profileS M Dursun, M A Reveley
Lancet (London, England)|September 18, 1993
SuicideM A Reveley, S M Dursun
Human Psychopharmacology|December 22, 2007
Neurological complications of psychiatric drugs: clinical features and managementPeter M Haddad, Serdar M Dursun
Human Psychopharmacology|December 22, 2007
Improving drug safety and tolerability in psychiatric clinical practicePeter M Haddad, Serdar M Dursun
Pageof 19

Showing results (21-30 of 190) with videos related to

Sort By:
Pageof 19
The American Journal of Medicine|May 1, 1995
Hypocholesterolemia and human immunodeficiency virus-1 (HIV-1) infectionS M Dursun, M A Reveley
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1994
Obsessive-compulsive symptoms and clozapineS M Dursun, M A Reveley
Journal of Psychopharmacology (Oxford, England)|October 19, 2006
Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapyHenry A Nasrallah, Serdar M Dursun
British Journal of Pharmacology|August 1, 1993
The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouseS M Dursun, S L Handley
Psychological Medicine|March 1, 1997
Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open studyS M Dursun, M A Reveley
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1992
Serotonin, eating disorders, and HIV infectionS M Dursun, S L Handley
BMJ (Clinical Research Ed.)|July 17, 1993
Clozapine in the management of schizophrenia. Clozapine has unique pharmacological profileS M Dursun, M A Reveley
Lancet (London, England)|September 18, 1993
SuicideM A Reveley, S M Dursun
Human Psychopharmacology|December 22, 2007
Neurological complications of psychiatric drugs: clinical features and managementPeter M Haddad, Serdar M Dursun
Human Psychopharmacology|December 22, 2007
Improving drug safety and tolerability in psychiatric clinical practicePeter M Haddad, Serdar M Dursun
Pageof 19